Mokari Atabak
SEC CIK 1678419 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | CFO | 16.3K | — | $18.73M | 35 | 2022-09-01 | 2026-09-02 |
Most active insiders at CORT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Maduck Sean | See Remarks | — | $23.27M |
| 2 | Mokari Atabak | CFO | — | $18.73M |
| 3 | Guyer William | Chief Development Off | — | $15.27M |
| 4 | MAHONEY DAVID L | Dir | — | $13.94M |
| 5 | BELANOFF JOSEPH K | CEO, Dir | — | $13.79M |
| 6 | Vieira Roberto Wandenkolk | Pres, Oncology | — | $6.49M |
| 7 | WILSON JAMES N | Dir | — | $3.94M |
| 8 | BAKER G LEONARD JR | Dir | $3.31M | — |
| 9 | Park Kimberly | Dir | — | $3.27M |
| 10 | Lyon Joseph Douglas | See Remarks | — | $2.83M |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-03 21:06 | 2026-09-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $56.69 | +276 | 16.4K | +2% | +$15.6K |
| 2026-09-03 21:06 | 2026-09-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $113.38 | -102 | 16.3K | -0.6% | -$11.6K | |
| DT | 2026-08-03 16:30 | 2026-07-30 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | M - OptEx | $23.06 | +80.0K | 96.1K | +496% | +$1.84M |
| DMT | 2026-08-03 16:30 | 2026-07-30 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | S - Sale+OE | $114.71 | -80.0K | 16.1K | -83% | -$9.18M |
| DMT | 2026-07-17 18:31 | 2026-07-15 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | M - OptEx | $21.56 | +40.0K | 56.1K | +248% | +$862.2K |
| DMT | 2026-07-17 18:31 | 2026-07-15 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | S - Sale+OE | $87.71 | -40.0K | 16.1K | -71% | -$3.51M |
| DT | 2026-06-17 16:30 | 2026-06-15 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | M - OptEx | $19.26 | +40.0K | 56.1K | +248% | +$770.4K |
| DMT | 2026-06-17 16:30 | 2026-06-15 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | S - Sale+OE | $81.15 | -40.0K | 16.1K | -71% | -$3.25M |
| DT | 2026-06-03 19:20 | 2026-06-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | M - OptEx | $19.26 | +40.0K | 55.3K | +262% | +$770.4K |
| DT | 2026-06-03 19:20 | 2026-06-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | S - Sale+OE | $70.00 | -40.0K | 15.3K | -72% | -$2.80M |
| DMT | 2026-06-03 19:20 | 2026-06-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $35.22 | +1,268 | 16.5K | +8% | +$44.7K |
| DT | 2026-06-03 19:20 | 2026-06-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $70.44 | -395 | 16.1K | -2% | -$27.8K |
| M | 2026-03-04 | 2026-03-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $17.98 | +794 | 15.4K | +5% | +$14.3K |
| 2026-03-04 | 2026-03-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $35.97 | -96 | 15.3K | -0.6% | -$3,453 | |
| M | 2025-12-03 | 2025-12-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $39.89 | +356 | 14.7K | +2% | +$14.2K |
| 2025-12-03 | 2025-12-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $79.78 | -118 | 14.6K | -0.8% | -$9,414 | |
| M | 2025-09-04 | 2025-09-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $35.69 | +400 | 14.5K | +3% | +$14.3K |
| 2025-09-04 | 2025-09-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $71.38 | -144 | 14.3K | -1.0% | -$10.3K | |
| M | 2025-06-04 | 2025-06-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $35.84 | +1,550 | 13.8K | +13% | +$55.6K |
| 2025-06-04 | 2025-06-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $71.68 | -519 | 14.1K | -4% | -$37.2K | |
| D | 2025-03-04 | 2025-03-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $60.58 | -228 | 12.6K | -2% | -$13.8K |
| DM | 2025-03-04 | 2025-03-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $29.54 | +464 | 13.0K | +4% | +$13.7K |
| M | 2024-12-04 | 2024-12-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $29.61 | +462 | 12.6K | +4% | +$13.7K |
| 2024-12-04 | 2024-12-02 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $57.68 | -182 | 12.3K | -1% | -$10.5K | |
| 2024-09-05 | 2024-09-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $35.30 | -143 | 11.7K | -1% | -$5,048 | |
| M | 2024-09-05 | 2024-09-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $17.13 | +800 | 12.1K | +7% | +$13.7K |
| 2024-06-05 | 2024-06-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $30.17 | -571 | 8,965 | -6% | -$17.2K | |
| M | 2024-06-05 | 2024-06-03 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $15.65 | +2,896 | 11.9K | +32% | +$45.3K |
| 2024-03-05 | 2024-03-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | F - Tax | $24.06 | -517 | 8,428 | -6% | -$12.4K | |
| M | 2024-03-05 | 2024-03-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $12.03 | +1,108 | 8,982 | +14% | +$13.3K |
| M | 2023-12-05 | 2023-12-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $12.98 | +1,016 | 8,437 | +14% | +$13.2K |
| M | 2023-09-06 | 2023-09-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $16.55 | +796 | 8,204 | +11% | +$13.2K |
| M | 2023-06-05 | 2023-06-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $11.49 | +3,302 | 5,757 | +135% | +$37.9K |
| M | 2023-03-03 | 2023-03-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $9.93 | +2,520 | 2,846 | +773% | +$25.0K |
| M | 2022-09-06 | 2022-09-01 | CORT | CORCEPT THERAPEUTICS INC | Mokari Atabak | CFO | A - Grant | $12.99 | +1,586 | 1,586 | New | +$20.6K |
Purchase Sale Sale after option exercise All abbreviations